{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:08:08Z","timestamp":1791414488433,"version":"4.3.3"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00562","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T05:38:45Z","timestamp":1588657125000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Verapamil and Alzheimer\u2019s Disease: Past, Present, and Future"],"prefix":"10.3389","volume":"11","author":[{"given":"Natalija","family":"Popovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicanor","family":"Morales-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vidal Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Pascual Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Caballero Bleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroljub","family":"Popovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.2042-7158.2011.01309.x","article-title":"Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer\u2019s disease","volume":"63","author":"Abuznait","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1254\/jjp.41.431","article-title":"Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by verapamil","volume":"41","author":"Adachi","year":"1986","journal-title":"Jpn. J. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.burns.2013.09.029","article-title":"Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids","volume":"40","author":"Ahuja","year":"2014","journal-title":"Burns"},{"key":"B4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jalz.2016.12.006","article-title":"Calcium Hypothesis of Alzheimer\u2019s disease and brain aging: a framework for integrating new evidence into a comprehensive theory of pathogenesis","volume":"13","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"B5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","article-title":"L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer\u2019s disease","volume":"41","author":"Anekonda","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","article-title":"The Alzheimer\u2019s disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri","year":"2019","journal-title":"Med. Clin. North. Am."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.2174\/138161211797440122","article-title":"Blood-brain barrier P-glycoprotein function in neurodegenerative disease","volume":"17","author":"Bartels","year":"2011","journal-title":"Curr. Pham. Des."},{"key":"B8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0014-2999(86)90752-1","article-title":"Effects of verapamil on the binding characteristics of muscarinic receptor subtypes","volume":"126","author":"Baumgold","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/bj3260539","article-title":"P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain","volume":"326","author":"Beaulieu","year":"1997","journal-title":"Biochem. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/jemt.10090","article-title":"Functional expression and localization of P-glycoprotein at the blood brain barrier","volume":"57","author":"Bendayan","year":"2002","journal-title":"Microsc. Res. Ech."},{"key":"B11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/nrc.1011","article-title":"NADPH-diaphorase activity in the frontal cortex of NBM-lesioned rats treated with verapamil","volume":"28","author":"Caballero-Bleda","year":"2001","journal-title":"Neurosci. Res. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/mol.51.5.872","article-title":"Inhibition of recombinant Ca2+ channels by benzothiazepines and phenylalkylamines: class-specific pharmacology and underlying molecular determinants","volume":"51","author":"Cai","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11940-017-0460-7","article-title":"Reversible cerebral vasoconstriction syndrome: recognition and treatment","volume":"19","author":"Cappelen-Smith","year":"2017","journal-title":"Curr. Treat. Options Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00592-019-01370-1","article-title":"The \u03b2\u2212cell effect of verapamil\u2212based treatment in patients with type 2 diabetes: a systematic review","volume":"57","author":"Carnovale","year":"2019","journal-title":"Acta Diabetol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2018.04.002","article-title":"Treatments for diabetes mellitus type II: new perspectives regarding the possible role of calcium and cAMP interaction","volume":"830","author":"Carvalho","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/febs.15148","article-title":"P-glycoprotein: a role in the export of amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"287","author":"Chai","year":"2019","journal-title":"FEBS J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/mp.2016.86","article-title":"A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development","volume":"21","author":"Cipriani","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.biopsych.2012.11.021","article-title":"The circadian system in Alzheimer\u2019s disease: disturbances, mechanisms, and opportunities","volume":"74","author":"Coogan","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/bdd.512","article-title":"The effect of gender on the pharmacokinetics of verapamil and norverapamil in human","volume":"27","author":"Dadashzadeh","year":"2006","journal-title":"Biopharm. Drug Dispos."},{"key":"B23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JAD-130560","article-title":"Cav1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-\u03b2 plaques in an Alzheimer\u2019s disease mouse model","volume":"37","author":"Daschil","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease","volume":"285","author":"Demuro","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1749-6632.1994.tb44424.x","article-title":"The calcium rationale in aging and Alzheimer\u2019s disease. Evidence from an animal model of normal aging","volume":"747","author":"Disterhoft","year":"1994","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/sj.bjp.0702574","article-title":"The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum","volume":"127","author":"Dobrev","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/17425255.2019.1558206","article-title":"Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorder","volume":"15","author":"Dubovsky","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0165-6147(94)90057-4","article-title":"Inflammatory mechanisms in Alzheimer\u2019s disease","volume":"15","author":"Eikelenboom","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev.pa.17.040177.001053","article-title":"Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle","volume":"17","author":"Fleckenstein","year":"1977","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00206","article-title":"Suggesting a way to understand the actual potential of anti-Alzheimer\u2019s disease drugs that show promise in transgenic mouse models","volume":"6","author":"Franco","year":"2015","journal-title":"Front. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1152\/jn.00992.2002","article-title":"A\u03b225-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil","volume":"89","author":"Freir","year":"2003","journal-title":"J. Neurophysiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00337","article-title":"Friend, foe or both? Immune activity in Alzheimer\u2019s disease","volume":"11","author":"Frost","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1476-5381.1983.tb08817.x","article-title":"Presynaptic alpha 2-adrenoceptor antagonism by verapamil but not by diltiazem in rabbit hypothalamic slices","volume":"78","author":"Galzin","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00002826-199306000-00011","article-title":"Parkinsonism unmasked by verapamil","volume":"16","author":"Garc\u00eda-Albea","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biopsych.2017.06.017","article-title":"Activity-dependent BDNF release is required for the rapid antidepressant actions of scopolamine","volume":"83","author":"Ghosal","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00566","article-title":"Verapamil blocks scopolamine enhancement effect on memory consolidation in passive avoidance task in rats","volume":"8","author":"Gim\u00e9nez de Bejar","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1476-5381.1990.tb14651.x","article-title":"The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice","volume":"99","author":"Green","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2125.1995.tb04554.x","article-title":"Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil","volume":"40","author":"Gupta","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain."},{"key":"B40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuropharm.2012.05.033","article-title":"Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers","volume":"63","author":"Hashioka","year":"2012","journal-title":"Neuropharmacology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Henaka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/01.mnh.0000174144.07174.74","article-title":"Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure","volume":"14","author":"Hermida","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B43","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.addr.2006.09.021","article-title":"Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure","volume":"59","author":"Hermida","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuro.2017.03.006","article-title":"Risk factors associated with the onset and progression of Alzheimer\u2019s disease: a systematic review of the evidence","volume":"61","author":"Hersi","year":"2017","journal-title":"Neurotoxicology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-8993(95)00815-8","article-title":"Block of P-type Ca2+ channels in freshly dissociated rat cerebellar Purkinje neurons by diltiazem and verapamil","volume":"695","author":"Ishibashi","year":"1995","journal-title":"Brain Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/bf00562555","article-title":"Circadian variation in the pharmacokinetics of verapamil","volume":"37","author":"Jespersen","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1989.tb12485.x","article-title":"Calcium, membranes, aging, and Alzheimer\u2019s disease. Introduction and overview","volume":"568","author":"Khachaturian","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10059-011-0075-x","article-title":"Effects of Amyloid-\u03b2 peptides on voltage-gated L-type Cav1.2 and Cav1.3 Ca2+ channels","volume":"32","author":"Kim","year":"2011","journal-title":"Mol. Cells"},{"key":"B49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12779\/dnd.2019.18.2.33","article-title":"A therapeutic strategy for Alzheimer\u2019s disease focused on immune-inflammatory modulation","volume":"18","author":"Kim","year":"2019","journal-title":"Dement. Neurocogn. Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population-based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"B51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/00912700022008883","article-title":"Gender-specific effects on verapamil pharmacokinetics an7d pharmacodynamics in humans","volume":"40","author":"Krecic-Shepard","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/pgmj.50.585.447","article-title":"Verapamil in the treatment of paroxysmal supraventicular tachycardia","volume":"50","author":"Krikler","year":"1974","journal-title":"Postgrad. Med. J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1750-3639.2007.00075.x","article-title":"MDR1-P-Glycoprotein (ABCB1) Mediates transport of Alzheimer\u2019s amyloid-\u03b2 peptides\u2013implications for the mechanisms of A\u03b2 clearance at the blood-brain barrier","volume":"17","author":"Kuhnke","year":"2007","journal-title":"Brain Pathol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-015-4095-7","article-title":"Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction","volume":"233","author":"Kumar","year":"2016","journal-title":"Psychopharmacol. (Berl)."},{"key":"B55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/adt.2013.552","article-title":"Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays","volume":"12","author":"Kuryshev","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejphar.2010.09.001","article-title":"Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via antiacetylcholinesterase and anti-oxidative activities in mice","volume":"649","author":"Kwon","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signaling in Alzheimer\u00b4s disease","volume":"3","author":"LaFerla","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"\u03b2-amyloid efflux mediated by p-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"J. Neurochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1517\/14728222.2013.823161","article-title":"The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases","volume":"17","author":"Lam","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"B60","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1007\/s10072-017-2924-7","article-title":"Cluster headache: present and future therapy","volume":"38","author":"Leone","year":"2017","journal-title":"Neurol. Sci."},{"key":"B61","first-page":"351","article-title":"The treatment of hypertension with verapamil","volume":"87","author":"Lewis","year":"1978","journal-title":"N.Z. Med. J."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in Alzheimer\u00b4s disease","volume":"8","author":"Li","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00203","article-title":"Targeting autophagy for the treatment of Alzheimer\u2019s disease: challenges and opportunities","volume":"12","author":"Liu","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2010.10.002","article-title":"Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation","volume":"60","author":"Liu","year":"2011","journal-title":"Neuropharmacology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/bmj.1.5850.375","article-title":"Double-blind evaluation of verapamil, propranolol and isosorbide dinitrate against placebo in the treatment of angina pectoris","volume":"1","author":"Livesley","year":"1973","journal-title":"Br. Med. J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer\u2019s disease","volume":"131","author":"Love","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/s0969-8051(03)00078-7","article-title":"(R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation","volume":"30","author":"Luurtsema","year":"2003","journal-title":"Nucl. Med. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimer\u2019s. Dement."},{"key":"B69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11926-015-0521-4","article-title":"Voltage-dependent calcium channels in chondrocytes: Roles in health and disease","volume":"17","author":"Matta","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/bmj.319.7213.806b","article-title":"Calcium-channel blockers and cognitive function in elderly people: results from the Canadian study of health and aging","volume":"161","author":"Maxwell","year":"1999","journal-title":"CMAJ"},{"key":"B71","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/JAD-2010-1219","article-title":"Neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment: a field in its infancy","volume":"19","author":"McGeer","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1017\/s0317167100029863","article-title":"Immune system response in Alzheimer\u00b4s disease","volume":"16","author":"McGeer","year":"1989","journal-title":"Can. J. Neurol. Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1212\/WNL.0000000000004741","article-title":"Blood pressure from mid- to late life and risk of incident dementia","volume":"89","author":"McGrath","year":"2017","journal-title":"Neurology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-017-2276-2","article-title":"Verapamil inhibits Ser202\/Thr205 phosphorylation of tau by blocking TXNIP\/ROS\/p38 MAPK pathway","author":"Melone","year":"2018","journal-title":"Pharm. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1526-4610.1983.hed2306266.x","article-title":"Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches","volume":"23","author":"Meyer","year":"1983","journal-title":"Headache."},{"key":"B76","doi-asserted-by":"publisher","first-page":"165S","DOI":"10.1111\/j.1365-2125.1986.tb02867.x","article-title":"Studies on verapamil in the treatment of essential hypertension: a review","volume":"21","author":"Midtb\u00f8","year":"1986","journal-title":"Br. J. Clin. Pharamacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.wjorl.2018.07.002","article-title":"P-glycoprotein and chronic rhinosinusitis","volume":"4","author":"Miyake","year":"2018","journal-title":"World J. Otorhinolaryngol. Head Neck Surg."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1152\/jn.00301.2009","article-title":"Enhanced calcium buffering in F344 rat cholinergic basal forebrain neurons is associated with age-related cognitive impairment","volume":"102","author":"Murchison","year":"2009","journal-title":"J. Neurophysiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"97S","DOI":"10.1111\/j.1365-2125.1986.tb02859.x","article-title":"Calcium antagonists and their mode of action: an historical overview","volume":"21","author":"Nayler","year":"1986","journal-title":"Br. J. Clin. Pharmac."},{"key":"B80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1586\/14737175.2016.1121097","article-title":"The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy","volume":"16","author":"Nicita","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/bph.12240","article-title":"Calcium channel blockers and dementia","volume":"169","author":"Nimmrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1523\/JNEUROSCI.4771-07.2008","article-title":"Amyloid \u03b2 oligomers (A\u03b21-42 globulomer) suppress spontaneous synaptic activity by inhibition of P\/Q-type calcium currents","volume":"28","author":"Nimmrich","year":"2008","journal-title":"J. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/ENEURO.0160-17.2017","article-title":"Calcium circadian rhythmicity in the suprachiasmatic nucleus: cell autonomy and network modulation","volume":"4","author":"Noguchi","year":"2017","journal-title":"eNeuro"},{"key":"B84","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10571-013-9952-5","article-title":"Neuromodulatory propensity of Bacopa monniera against scopolamine-induced cytotoxicity in PC12 cells via down-regulation of AChE and up-regulation of BDNF and muscarnic-1 receptor expression","volume":"33","author":"Pandareesh","year":"2013","journal-title":"Cell Mol. Neurobiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.4161\/15548627.2014.984268","article-title":"Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies","volume":"10","author":"Park","year":"2014","journal-title":"Autophagy"},{"key":"B86","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/hrt.41.2.167","article-title":"Management of unstable angina at rest by verapamil. A double-blind crossover study in coronary care unit","volume":"41","author":"Parodi","year":"1979","journal-title":"Br. Heart J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/aje\/kwr362","article-title":"Use of calcium channel blockers and Parkinson\u2019s disease","volume":"175","author":"Pasternak","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ceca.2017.06.008","article-title":"Calcium signaling and molecular mechanisms underlying neurodegenerative diseases","volume":"70","author":"Pchitskaya","year":"2018","journal-title":"Cell Calcium"},{"key":"B89","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.phrs.2018.01.018","article-title":"Synaptic plasticity modulation by circulating peptides and metaplasticity: involvement in Alzheimer\u2019s disease","volume":"130","author":"Peineau","year":"2018","journal-title":"Pharmacol. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/head.13603","article-title":"Verapamil and cluster headache: Still a mystery. A narrative review of efficacy, mechanisms and perspectives","volume":"59","author":"Petersen","year":"2019","journal-title":"Headache"},{"key":"B91","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11011-019-00498-x","article-title":"Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury\u2013 a potential agent for Alzheimer\u2019s disease","volume":"35","author":"Ponne","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0306-3623(90)90830-f","article-title":"Effects of the Ca2+-antagonists nifedipine, verapamil, flunarizine and of the calmodulin antagonist trifluoperazine on muscarinic cholinergic receptors in rat cerebral cortex","volume":"21","author":"Popova","year":"1990","journal-title":"Gen. Pharmacol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0306-3623(91)90593-u","article-title":"The long-term treatment with the Ca2+-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine decreases the activity of 5-HT1 receptors in rat cerebral cortex and hippocampus","volume":"22","author":"Popova","year":"1991","journal-title":"Gen. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/00207459709000628","article-title":"Effect of physostigmine and verapamil on active avoidance in an experimental model of Alzheimer\u00b4s disease","volume":"90","author":"Popovi\u0107","year":"1997","journal-title":"Int. J. Neurosci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/00207459708986375","article-title":"Open field behavior in nucleus basalis magnocellularis-lesioned rats treated with physostigmine and verapamil","volume":"91","author":"Popovi\u0107","year":"1997","journal-title":"Int. J. Neurosci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/00207459708986392","article-title":"Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits in an experimental Alzheimer\u2019s disease in rats","volume":"92","author":"Popovi\u0107","year":"1997","journal-title":"Int. J. Neurosci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/00207459809003341","article-title":"Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer\u00b4s disease","volume":"95","author":"Popovi\u0107","year":"1998","journal-title":"Int. J. Neurosci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/s1520-6769(199807\/08)23:1<13::AID-NRC2>3.0.CO;2-O","article-title":"Effect of acute physostigmine and verapamil treatment on aggressive and depressive behavior in rats with lesioned nucleus basalis magnocellularis","volume":"23","author":"Popovi\u0107","year":"1998","journal-title":"Neurosci. Res. Commun."},{"key":"B99","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/(SICI)1520-6769(199811\/12)23:3<181::AID-NRC6>3.0.CO;2-E","article-title":"Effect of acute verapamil treatment on body temperatura in nucleus basalis magnocellularis-lesioned rats","volume":"23","author":"Popovi\u0107","year":"1998","journal-title":"Neurosci. Res. Commun."},{"key":"B100","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/(SICI)1520-6769(199911\/12)25:3<163::AID-NRC5>3.0.CO;2-4","article-title":"Effect of acute verapamil treatment on cold restraint-induced gastric lesions in rats with lesioned nucleus basalis magnocellularis","volume":"25","author":"Popovi\u0107","year":"1999","journal-title":"Neurosci. Res. Commun."},{"key":"B101","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00221-005-0219-3","article-title":"Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis","volume":"170","author":"Popovi\u0107","year":"2006","journal-title":"Exp. Brain Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/01.STR.0000133128.42462.ef","article-title":"Decline in blood pressure over time and risk of dementia. A longitudinal study from the Kungsholmen project","volume":"35","author":"Qiu","year":"2004","journal-title":"Stroke"},{"key":"B103","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/s0006-8993(02)03547-3","article-title":"Modulation of Ca2+ channel currents in primary cultures of rat cortical neurones by amyloid beta protein (1-40) is dependent on solubility status","volume":"956","author":"Ramsden","year":"2002","journal-title":"Brain Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tips.2015.05.005","article-title":"Exploring the potential of adjunct therapy in tuberculosis","volume":"36","author":"Rayasam","year":"2015","journal-title":"Trends Pharmcol. Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.neurobiolaging.2013.10.090","article-title":"Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production","volume":"35","author":"Rice","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B106","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0022-510X(87)90260-7","article-title":"Neuronal size and density in the nucleus basalis of Meynert in Alzheimer`s disesase","volume":"79","author":"Rinne","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.eururo.2018.07.005","article-title":"Clinical efficacy of injection and mechanical therapy for Peyronie\u2019s disease: a systematic review of the literature","volume":"74","author":"Russo","year":"2018","journal-title":"Eur. Urol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.chemosphere.2017.09.058","article-title":"Global scanning assessment of calcium channel blockers in the environment: Review and analysis of occurrence, ecotoxicology and hazards in aquatic systems","volume":"189","author":"Saari","year":"2017","journal-title":"Chemosphere"},{"key":"B109","doi-asserted-by":"publisher","first-page":"278.285","DOI":"10.1038\/clpt.1993.148","article-title":"The effects of age and gender on the stereoselective pharmacokinetics of verapamil","volume":"54","author":"Sasaki","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/bmj.1.5801.660","article-title":"Immediate effects of intravenous verapamil in cardiac arrhythmias","volume":"1","author":"Schamroth","year":"1972","journal-title":"Br. Med. J."},{"key":"B111","first-page":"690","article-title":"Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil","volume":"265","author":"Schwartz","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B112","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/clpt.1994.64","article-title":"Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics","volume":"55","author":"Schwartz","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"B113","first-page":"364","article-title":"Aging alters verapamil elimination and dynamics: single dose and steady-state responses","volume":"255","author":"Schwartz","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B114","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2165\/00002512-199609010-00003","article-title":"Calcium antagonists in the elderly. A risk-benefit analysis","volume":"9","author":"Schwartz","year":"1996","journal-title":"Drugs Aging"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.18203\/2319-2003.ijbcp20163262","article-title":"The effect of calcium channel blockers against scopolamine induced cognitive impairment and oxidative stress","volume":"5","author":"Sekhar","year":"2016","journal-title":"Int. J. Basic Clin. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0006-8993(93)90505-H","article-title":"Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer\u2019s, Parkinson\u2019s and Huntington\u2019s diseases","volume":"611","author":"Sen","year":"1993","journal-title":"Brain Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00221-007-1133-7","article-title":"The metabolism of serotonin in neuronal cells in culture and platelets","volume":"183","author":"Shad","year":"2007","journal-title":"Exp. Brain Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0006-8993(98)01272-4","article-title":"Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels","volume":"818","author":"Silei","year":"1999","journal-title":"Brain Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/NEN.0b013e3181f46e25","article-title":"Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging","volume":"69","author":"Silverberg","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","article-title":"Monoaminergic neuropathology in Alzheimer\u00b4s disease","volume":"151","author":"\u0160imi\u0107","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0924-977x(97)00053-9","article-title":"Chronic verapamil modifies striatal and frontal cortex dopamine levels","volume":"8","author":"Sitges","year":"1998","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/s0140-6736(96)90608-x","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"B123","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijantimicag.2016.04.007","article-title":"Development of efflux pump inhibitors in antituberculosis therapy","volume":"47","author":"Song","year":"2016","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B124","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0306-3623(90)90611-o","article-title":"Influence of long-term treatment with the Ca2(+)-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine on beta-adrenoceptors in rat cerebral cortex","volume":"21","author":"Staneva-Stoytcheva","year":"1990","journal-title":"Gen. Pharmacol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/0306-3623(91)90594-V","article-title":"Changes in benzodiazepine receptors of rat brain after long-term treatment with the Ca2+-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine","volume":"22","author":"Staneva-Stoytcheva","year":"1991","journal-title":"Gen. Pharmacol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0306-3623(92)90048-o","article-title":"Long-term treatment with different calcium- and calmodulin-antagonists induces changes in rat brain alpha-adrenoceptors","volume":"23","author":"Staneva-Stoytcheva","year":"1992","journal-title":"Gen. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction and Alzheimer\u00b4s disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"A28","DOI":"10.1136\/heartjnl-2013-303992.086","article-title":"The effects of verapamil on SK2 channel in myocardium cells from human chronic atrial fibrillation","volume":"99","author":"Tao","year":"2013","journal-title":"Heart"},{"key":"B129","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2007.06.050","article-title":"Effects of phyenilalkylamines and benzothiazepines on Cav1.3-mediated Ca2+ currents in neonatal mouse inner hair cells","volume":"573","author":"Tarabova","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0014-2999(84)90703-9","article-title":"Inhibition of [3H]spiperone binding to 5-HT2 receptors of rat cerebral cortex by the calcium antagonists verapamil and D600","volume":"106","author":"Taylor","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1526-4610.2008.01298.x","article-title":"Verapamil for cluster headache. Clinical pharmacology and possible mode of action","volume":"49","author":"Tfelt-Hansen","year":"2009","journal-title":"Headache"},{"key":"B132","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1474-9726.2007.00295.x","article-title":"Expansion of the calcium hypothesis of brain aging and Alzheimer\u2019s disease: minding the store","volume":"6","author":"Thibault","year":"2007","journal-title":"Aging Cell"},{"key":"B133","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.seizure.2017.06.022","article-title":"Outside the box: Medications worth considering when traditional antiepileptic drugs have failed","volume":"50","author":"Turner","year":"2017","journal-title":"Seizure"},{"key":"B134","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11307-012-0556-0","article-title":"P-glycoprotein function at the blood\u2013brain barrier: Effects of age and gender","volume":"14","author":"van Assema","year":"2012","journal-title":"Mol. Imaging Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-2-1","article-title":"Reproducibility of quantitative (R)-[11C]verapamil studies","volume":"2","author":"van Assema","year":"2012","journal-title":"EJNMMI Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/DSS.0000000000000506","article-title":"Mechanism of action, efficacy, and adverse events of calcium antagonists in hypertrophic scars and keloids: a systematic review","volume":"41","author":"Verhiel","year":"2015","journal-title":"Dermatol. Surg"},{"key":"B137","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer\u2019s \u03b2-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"B138","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1567205043332225","article-title":"The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer\u2019s disease","volume":"1","author":"Vogelgesang","year":"2004","journal-title":"Curr. Alzheimer Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1096\/fj.201801751R","article-title":"Ca2+ homeostasis dysregulation in Alzheimer\u2019s disease: a focus on plasma membrane and cell organelles","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"key":"B140","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer\u2019s disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann. Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0197-4580(95)80002-9","article-title":"Neurotoxicity of A\u03b2 amyloid protein in vitro is not altered by calcium channel blockade","volume":"16","author":"Whitson","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"B142","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s0006-3223(01)01338-5","article-title":"Verapamil treatment for women with bipolar disorder","volume":"51","author":"Wisner","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"B143","doi-asserted-by":"publisher","first-page":"E9469","DOI":"10.1073\/pnas.1804300115","article-title":"Ultradian calcium rhythms in the paraventricular nucleus and subparaventricular zone in the hypothalamus","volume":"115","author":"Wu","year":"2018","journal-title":"PNAS"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112773","article-title":"Lactobacillus casei-01 facilitates the ameliorative effects of proanthocyanidins extracted from lotus seedpod on learning and memory impairment in scopolamine-induced amnesia mice","volume":"9","author":"Xiao","year":"2014","journal-title":"PloS One"},{"key":"B145","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: The Baltimore longitudinal study of aging","volume":"26","author":"Yaser","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1210\/jc.2016-3778","article-title":"Verapamil use is associated with reduction of newly diagnosed diabetes mellitus","volume":"102","author":"Yin","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B147","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/ijnp\/pyx080","article-title":"The requirement of L-type voltage-dependent calcium channel (L-VDCC) in the rapid-acting antidepressant-like effects of scopolamine in mice","volume":"21","author":"Yu","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00562\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T05:38:50Z","timestamp":1588657130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00562\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":147,"alternative-id":["10.3389\/fphar.2020.00562"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00562","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"article-number":"562"}}